ABL1 and neurodegenerative disease: Active c-Abl is implicated in a variety of neurodegenerative diseases, including Alzheimer’s (Alvarez et al., 2004; Cancino et al., 2008; Estrada et al., 2011; Gonzalez-Zuñiga et al., 2014) and Parkinson’s diseases (Imam et al., 2011).